We have located links that may give you full text access.
Results of an internal audit on the survival of patients with uterine sarcoma.
Journal of the Turkish German Gynecological Association 2018 October 10
OBJECTIVE: In the last 5 years there has been a lot of discussion about the surgical procedure for uterine fibroids and essentially also uterine sarcoma. Still there exist no reliable presurgical diagnostic tool to differentiate between benign fibroids and uterine sarcomas. The aim of this study was to confirm the suspected an association between intraoperative spread of tumor by morcellation and impaired outcome in sarcoma patients.
MATERIAL AND METHODS: After local ethics commission positively reviewed the study protocol the oncological database of our university hospital was retrospectively reviewed for patients with uterine sarcomas over a time period of 13 years (2002-2015). Data was extracted from the medical files and survival information was collected by contacting patient´s general practitioners if last follow-up-status was older than 6 months. For the analysis patients were split into two groups with either intrasurgical morcellation (M+) or no morcellation (M-) regarding information provided by the surgical report.
RESULTS: Data on 57 uterine sarcoma patients was available for further analysis. The median age was 63years with a BMI of 27 kg/m². The sarcoma subtypes were 25 leiomyosarcoma (LMS), 19 carcinosarcoma (KS), 9 endometriod stroma sarcoma (ESS), 3 adenosarcoma (AS) and one case without further differentiation. In the majority, no morcellation was done (44 patients in M- group) and 51 patients received open surgery (3 laparoscopic, 1 vaginal and 2 incomplete surgeries). Median time of follow-up was 31 months. The disease free survival was 50.5 months and the cox regressions analysis showed a hazard ratio of 3.06 (no significant difference between the two subgroups (p=0.079; 95%-KI: 0.9 - 10.6)). The overall survival was found to be 62.2 months and the cox regression analysis showed a hazard ratio of 3.216 with statistical significantdifference between the two subgroups (p=0.013; 95%-KI: 1.3 - 8.1).
CONCLUSION: Despite the efforts to find a pre-surgical diagnostic tool, the clinical situation remains unsatisfactory. Overall sarcoma prevalence is low during the last 13 years at our university center, but morcellation occurred in a relevant portion of patients (13 out of 57). If a sarcoma is suspected or diagnosed the en-bloc resection of the uterus can prolong the survival. Thus, morcellation of the uterus and not the surgical technique (en-bloc resection) is the prognostic factor and should be avoided in any suspicious case.
MATERIAL AND METHODS: After local ethics commission positively reviewed the study protocol the oncological database of our university hospital was retrospectively reviewed for patients with uterine sarcomas over a time period of 13 years (2002-2015). Data was extracted from the medical files and survival information was collected by contacting patient´s general practitioners if last follow-up-status was older than 6 months. For the analysis patients were split into two groups with either intrasurgical morcellation (M+) or no morcellation (M-) regarding information provided by the surgical report.
RESULTS: Data on 57 uterine sarcoma patients was available for further analysis. The median age was 63years with a BMI of 27 kg/m². The sarcoma subtypes were 25 leiomyosarcoma (LMS), 19 carcinosarcoma (KS), 9 endometriod stroma sarcoma (ESS), 3 adenosarcoma (AS) and one case without further differentiation. In the majority, no morcellation was done (44 patients in M- group) and 51 patients received open surgery (3 laparoscopic, 1 vaginal and 2 incomplete surgeries). Median time of follow-up was 31 months. The disease free survival was 50.5 months and the cox regressions analysis showed a hazard ratio of 3.06 (no significant difference between the two subgroups (p=0.079; 95%-KI: 0.9 - 10.6)). The overall survival was found to be 62.2 months and the cox regression analysis showed a hazard ratio of 3.216 with statistical significantdifference between the two subgroups (p=0.013; 95%-KI: 1.3 - 8.1).
CONCLUSION: Despite the efforts to find a pre-surgical diagnostic tool, the clinical situation remains unsatisfactory. Overall sarcoma prevalence is low during the last 13 years at our university center, but morcellation occurred in a relevant portion of patients (13 out of 57). If a sarcoma is suspected or diagnosed the en-bloc resection of the uterus can prolong the survival. Thus, morcellation of the uterus and not the surgical technique (en-bloc resection) is the prognostic factor and should be avoided in any suspicious case.
Full text links
Related Resources
Trending Papers
Challenges in Septic Shock: From New Hemodynamics to Blood Purification Therapies.Journal of Personalized Medicine 2024 Februrary 4
Molecular Targets of Novel Therapeutics for Diabetic Kidney Disease: A New Era of Nephroprotection.International Journal of Molecular Sciences 2024 April 4
The 'Ten Commandments' for the 2023 European Society of Cardiology guidelines for the management of endocarditis.European Heart Journal 2024 April 18
A Guide to the Use of Vasopressors and Inotropes for Patients in Shock.Journal of Intensive Care Medicine 2024 April 14
Diagnosis and Management of Cardiac Sarcoidosis: A Scientific Statement From the American Heart Association.Circulation 2024 April 19
Essential thrombocythaemia: A contemporary approach with new drugs on the horizon.British Journal of Haematology 2024 April 9
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app